Eledon Pharmaceuticals Inc. (ELDN) NASDAQ
$1.86 (0.13) (-6.53%)
Market Cap: $49.38M
As of 04/19/24 04:00 PM EDT. Market closed.
Eledon Pharmaceuticals Inc. (ELDN)
NASDAQ
$1.86
(0.13) (-6.53%)
Market Cap: $49.38M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
eledon pharmaceuticals, inc. is a clinical stage biotechnology company using its expertise in targeting the cd40l pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. our lead program, at-1501, is a potential best-in-class humanized igg1 anti-cd40l antibody with high affinity for cd40l, a ... read more
eledon pharmaceuticals, inc. is a clinical stage biotechnology company using its expertise in targeting the cd40l pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. our lead program, at-1501, is a potential best-in-class humanized igg1 anti-cd40l antibody with high affinity for cd40l, a well-validated biological target with broad therapeutic potential. the cd40/cd40l pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Gregory Flesher
Full Time Employees
16
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Gregory Flesher
Full Time Employees
16
Address
19900 MacArthur Blvd Ste 550, California, Irvine, 92612-8426.
PRICE CHART FOR ELEDON PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.09
Previous Close
$1.99
Days Range
$1.55 - $2
52 week range
$1.07 - $2.95
Volume
420,856
Avg. Volume (30 days)
143,818
Market Cap
$49.38M
Dividend Yield
-
P/E
-
Shares Outstanding
24,813,130
Open
$2.09
Previous Close
$1.99
Days Range
$1.55 - $2
52 week range
$1.07 - $2.95
Volume
420,856
Avg. Volume (30 days)
143,818
Market Cap
$49.38M
Dividend Yield
-
P/E
-
Shares Outstanding
24,813,130
FINANCIAL STATEMENTS FOR ELEDON PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ELEDON PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Perrin Steven | President | Nov 23, 2022 | Buy | $2.60 | 1,000 | 2,597 | 1,000 | Nov 23, 2022, 04:05 PM |
| Gros David-Alexandre C | Chief Executive Officer | Dec 20, 2021 | Buy | $4.48 | 2,000 | 8,960 | 9,000 | Dec 21, 2021, 04:05 PM |
| Gros David-Alexandre C | Chief Executive Officer | Aug 17, 2021 | Buy | $6.21 | 4,000 | 24,840 | 7,000 | Aug 19, 2021, 04:05 PM |
| Gros David-Alexandre C | Chief Executive Officer | Jun 09, 2021 | Buy | $8.01 | 3,000 | 24,030 | 3,000 | Jun 10, 2021, 05:25 PM |
| OrbiMed Israel GP Ltd. | 10% Owner | Dec 02, 2020 | Sale | $21.60 | 103,200 | 2,229,120 | 73,650 | Dec 04, 2020, 05:17 PM |
| Logos Global Management LP | 10% Owner | Oct 30, 2020 | Buy | $25.44 | 92,040 | 2,341,714 | 224,071 | Nov 06, 2020, 06:46 PM |
| Logos Global Management LP | 10% Owner | Oct 30, 2020 | Sale | $26.64 | 12,969 | 345,559 | 199,973 | Nov 06, 2020, 06:46 PM |
| TURKEL CATHERINE C. | President | May 21, 2019 | Sale | $1.91 | 1,914 | 3,658 | 88,662 | May 22, 2019, 04:12 PM |
| TURKEL CATHERINE C. | President | May 20, 2019 | Sale | $1.96 | 7,623 | 14,953 | 90,576 | May 22, 2019, 04:12 PM |
| Kuwahara Jon | See Remarks | May 21, 2019 | Sale | $1.91 | 1,058 | 2,022 | 5,974 | May 22, 2019, 04:02 PM |
| Kuwahara Jon | See Remarks | May 20, 2019 | Sale | $1.96 | 4,218 | 8,274 | 7,032 | May 22, 2019, 04:02 PM |
| FLESHER GREGORY J. | Chief Executive Officer | May 20, 2019 | Sale | $1.96 | 11,701 | 22,953 | 159,855 | May 22, 2019, 04:01 PM |
| FLESHER GREGORY J. | Chief Executive Officer | May 21, 2019 | Sale | $1.91 | 2,937 | 5,614 | 156,918 | May 22, 2019, 04:01 PM |
| OrbiMed Israel GP Ltd. | Director | May 02, 2019 | Buy | $3.10 | 646,204 | 2,003,232 | 3,183,314 | May 06, 2019, 05:30 PM |
| Chimovits Erez | Director | May 02, 2019 | Buy | $3.10 | 646,204 | 2,003,232 | 3,183,314 | May 06, 2019, 05:28 PM |
| LIFESCI INDEX PARTNERS LLC | 10% Owner | Apr 30, 2019 | Sale | $2.70 | 200 | 540 | 1,065,867 | May 02, 2019, 04:47 PM |
| TURKEL CATHERINE C. | President | Sep 11, 2018 | Buy | $4.56 | 17,048 | 77,671 | 61,567 | Sep 13, 2018, 08:00 PM |
| TURKEL CATHERINE C. | President | Sep 12, 2018 | Buy | $5.02 | 16,632 | 83,476 | 78,199 | Sep 13, 2018, 08:00 PM |
| TURKEL CATHERINE C. | President | Sep 05, 2018 | Buy | $3.97 | 805 | 3,193 | 805 | Sep 07, 2018, 08:00 PM |
| FLESHER GREGORY J. | Chief Executive Officer | May 10, 2017 | Buy | $9.99 | 58,959 | 589,000 | 115,856 | May 11, 2017, 08:36 PM |
| TURKEL CATHERINE C. | Chief Development Officer | May 10, 2017 | Buy | $9.99 | 11,111 | 110,999 | 24,519 | May 11, 2017, 08:33 PM |
| OCAMPO CHRISTINE | See Remarks | May 10, 2017 | Buy | $9.99 | 10,010 | 100,000 | 21,590 | May 11, 2017, 08:30 PM |
| Buckley Stephen Jr. | Director | Mar 15, 2016 | Buy | $5.74 | 8,000 | 45,920 | 11,000 | Mar 15, 2016, 04:02 PM |
| Morrison Jodie Pope | President and CEO | Jan 08, 2016 | Option Exercise | $1.16 | 28,015 | 32,449 | 57,566 | Jan 08, 2016, 04:01 PM |
| Buckley Stephen Jr. | Director | Nov 11, 2015 | Buy | $11.25 | 3,000 | 33,750 | 3,000 | Nov 12, 2015, 09:06 AM |
| McBride John S. | Chief Operating Officer | Sep 21, 2015 | Option Exercise | $4.19 | 13,500 | 56,565 | 13,500 | Sep 22, 2015, 04:31 PM |
| McBride John S. | Chief Operating Officer | Sep 21, 2015 | Sale | $14.01 | 13,500 | 189,135 | 0 | Sep 22, 2015, 04:31 PM |
| Kalowski Lee | Chief Financial Officer | Sep 08, 2015 | Sale | $13.13 | 4,668 | 61,291 | 40,953 | Sep 08, 2015, 04:23 PM |
| Kalowski Lee | Chief Financial Officer | Sep 02, 2015 | Sale | $12.96 | 2,158 | 27,968 | 45,621 | Sep 04, 2015, 04:03 PM |
| Morrison Jodie Pope | President and CEO | Jul 28, 2015 | Option Exercise | $1.58 | 12,000 | 18,960 | 31,551 | Jul 30, 2015, 05:33 PM |
| Morrison Jodie Pope | President and CEO | Jul 29, 2015 | Option Exercise | $0.89 | 10,564 | 9,411 | 29,551 | Jul 30, 2015, 05:33 PM |
| Morrison Jodie Pope | President and CEO | Jul 29, 2015 | Sale | $13.70 | 564 | 7,727 | 19,551 | Jul 30, 2015, 05:33 PM |
| Morrison Jodie Pope | President and CEO | Jul 28, 2015 | Sale | $13.70 | 12,000 | 164,400 | 19,551 | Jul 30, 2015, 05:33 PM |
| Morrison Jodie Pope | Jul 22, 2015 | Option Exercise | $1.06 | 10,000 | 10,624 | 19,551 | Jul 24, 2015, 04:23 PM | |
| Novartis Bioventures Ltd | 10% Owner | Jul 15, 2015 | Sale | $14.26 | 3,566 | 50,844 | 4,493,458 | Jul 17, 2015, 04:05 PM |
| Novartis Bioventures Ltd | 10% Owner | Jul 14, 2015 | Sale | $14.41 | 27,861 | 401,477 | 4,497,024 | Jul 15, 2015, 04:18 PM |
| Novartis Bioventures Ltd | 10% Owner | Jul 13, 2015 | Sale | $14.20 | 20,611 | 292,717 | 4,524,885 | Jul 15, 2015, 04:18 PM |
| Morrison Jodie Pope | President and CEO | Jun 29, 2015 | Option Exercise | $1.58 | 8,000 | 12,640 | 17,551 | Jun 30, 2015, 04:48 PM |
| Morrison Jodie Pope | President and CEO | Jun 26, 2015 | Option Exercise | $1.58 | 8,000 | 12,640 | 17,551 | Jun 30, 2015, 04:48 PM |
| Morrison Jodie Pope | President and CEO | Jun 29, 2015 | Sale | $13.70 | 8,000 | 109,600 | 9,551 | Jun 30, 2015, 04:48 PM |
| Morrison Jodie Pope | President and CEO | Jun 26, 2015 | Sale | $13.83 | 8,000 | 110,640 | 9,551 | Jun 30, 2015, 04:48 PM |
| McBride John S. | Chief Operating Officer | Jun 24, 2015 | Option Exercise | $4.19 | 300 | 1,257 | 300 | Jun 24, 2015, 04:27 PM |
| McBride John S. | Chief Operating Officer | Jun 23, 2015 | Option Exercise | $4.19 | 6,700 | 28,073 | 6,700 | Jun 24, 2015, 04:27 PM |
| McBride John S. | Chief Operating Officer | Jun 22, 2015 | Option Exercise | $4.19 | 2,000 | 8,380 | 2,000 | Jun 24, 2015, 04:27 PM |
| McBride John S. | Chief Operating Officer | Jun 24, 2015 | Sale | $14.20 | 300 | 4,260 | 0 | Jun 24, 2015, 04:27 PM |
| McBride John S. | Chief Operating Officer | Jun 23, 2015 | Sale | $14.00 | 6,700 | 93,800 | 0 | Jun 24, 2015, 04:27 PM |
| McBride John S. | Chief Operating Officer | Jun 22, 2015 | Sale | $14.02 | 2,000 | 28,040 | 0 | Jun 24, 2015, 04:27 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 16, 2015 | Sale | $14.27 | 1,120 | 15,982 | 4,545,496 | Jun 18, 2015, 12:54 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 15, 2014 | Sale | $14.20 | 14,777 | 209,833 | 4,546,616 | Jun 16, 2015, 04:17 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 12, 2015 | Sale | $14.20 | 5,919 | 84,050 | 4,561,393 | Jun 16, 2015, 04:17 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 11, 2015 | Sale | $14.20 | 27,875 | 395,825 | 4,567,312 | Jun 12, 2015, 04:05 PM |
| Kalowski Lee | Chief Financial Officer | Apr 16, 2015 | Sale | $13.00 | 4,567 | 59,371 | 47,779 | Apr 20, 2015, 05:08 PM |
| Kalowski Lee | Chief Financial Officer | Apr 02, 2015 | Sale | $11.45 | 2,258 | 25,854 | 52,346 | Apr 06, 2015, 05:23 PM |
| Novartis Bioventures Ltd | 10% Owner | Mar 18, 2015 | Sale | $14.50 | 3,000 | 43,500 | 4,641,328 | Mar 20, 2015, 02:37 PM |
| Novartis Bioventures Ltd | 10% Owner | Mar 19, 2015 | Sale | $14.50 | 46,141 | 669,045 | 4,595,187 | Mar 20, 2015, 02:37 PM |
| Satter Muneer A | 10% Owner | Sep 22, 2014 | Buy | $15.00 | 150,000 | 2,250,000 | 1,771,688 | Sep 24, 2014, 05:54 PM |
| Apple Tree Partners II - Annex, L.P. | Director | Sep 22, 2014 | Buy | $15.00 | 237,500 | 3,562,500 | 3,568,438 | Sep 24, 2014, 05:52 PM |
| Harrison Seth Loring | Director | Sep 22, 2014 | Buy | $15.00 | 362,500 | 5,437,500 | 7,912,079 | Sep 24, 2014, 05:44 PM |
| Novartis Bioventures Ltd | 10% Owner | Sep 22, 2014 | Buy | $15.00 | 325,000 | 4,875,000 | 4,644,328 | Sep 24, 2014, 05:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN ELEDON PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 176,039 | 0.00003% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 69,173 | 0.00019% | 11.62% | Other |
| BLACKROCK INC. | 28,302 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR ELEDON PHARMACEUTICALS INC
STOCK BUYBACKS FOR ELEDON PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-17.87%
1Q
06/30/2023
2.55%
2Q
09/30/2022
72.57%
5Q
06/30/2022
72.57%
6Q
03/31/2022
71.79%
7Q
12/31/2021
66.17%
8Q
09/30/2021
66.17%
9Q
06/30/2021
66.17%
10Q
03/31/2021
66.00%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ELEDON PHARMACEUTICALS INC
LOADING...